Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Q3 2025 value amounting to 0.35.

  • Vanda Pharmaceuticals' Asset Utilization Ratio rose 1751.54% to 0.35 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.35, marking a year-over-year increase of 1751.54%. This contributed to the annual value of 0.3 for FY2024, which is 144.66% up from last year.
  • As of Q3 2025, Vanda Pharmaceuticals' Asset Utilization Ratio stood at 0.35, which was up 1751.54% from 0.32 recorded in Q2 2025.
  • In the past 5 years, Vanda Pharmaceuticals' Asset Utilization Ratio registered a high of 0.47 during Q1 2021, and its lowest value of 0.27 during Q1 2024.
  • In the last 5 years, Vanda Pharmaceuticals' Asset Utilization Ratio had a median value of 0.37 in 2023 and averaged 0.37.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first tumbled by 3199.75% in 2024, then skyrocketed by 1751.54% in 2025.
  • Vanda Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.46 in 2021, then decreased by 11.54% to 0.41 in 2022, then dropped by 26.27% to 0.3 in 2023, then rose by 2.29% to 0.31 in 2024, then increased by 13.26% to 0.35 in 2025.
  • Its Asset Utilization Ratio stands at 0.35 for Q3 2025, versus 0.32 for Q2 2025 and 0.31 for Q1 2025.